We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+2.97%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.72B
AUM Growth
-$344M
Cap. Flow
-$310M
Cap. Flow %
-18%
Top 10 Hldgs %
22.96%
Holding
279
New
14
Increased
72
Reduced
169
Closed
14

Top Buys

Rank Stock Value
1
TTGT icon
TechTarget
TTGT
+$9.17M
2
DOCS icon
Doximity
DOCS
+$7.51M
3
NXGN
NextGen Healthcare, Inc. Common Stock
NXGN
+$5.78M
4
CLNE icon
Clean Energy Fuels
CLNE
+$5.35M
5
ZUO
Zuora, Inc.
ZUO
+$4.15M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$26.8M
2
WNS
WNS Holdings
WNS
+$15.7M
3
SIMO icon
Silicon Motion
SIMO
+$14.8M
4
ON icon
ON Semiconductor
ON
+$13.2M
5
WWE
World Wrestling Entertainment
WWE
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 27.05%
2 Healthcare 26.07%
3 Industrials 15.04%
4 Consumer Discretionary 11.17%
5 Communication Services 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGTI
26
DELISTED
PGT, Inc.
PGTI
$17.5M 1.02%
836,359
-79,312
-9% -$1.63M
MTN icon
27
Vail Resorts
MTN
$5.3B
$17M 0.98%
78,702
-24,032
-23% -$5.46M
SMTC icon
28
Semtech
SMTC
$13B
$16.8M 0.98%
572,881
-170,322
-23% -$7.98M
NBIX icon
29
Neurocrine Biosciences
NBIX
$16.6B
$16.2M 0.94%
152,919
-49,627
-25% -$5.04M
OZK icon
30
Bank OZK
OZK
$5.61B
$16.2M 0.94%
409,068
-155,492
-28% -$6.26M
CMBM
31
DELISTED
Cambium Networks
CMBM
$15.8M 0.92%
936,605
+31,941
+4% +$573K
FC icon
32
Franklin Covey
FC
$246M
$15.8M 0.92%
347,880
+14,011
+4% +$693K
POOL icon
33
Pool Corp
POOL
$7.5B
$15.5M 0.9%
48,851
-19,808
-29% -$7.07M
QLYS icon
34
Qualys
QLYS
$6.35B
$15.5M 0.9%
111,209
-33,709
-23% -$4.75M
XPO icon
35
XPO
XPO
$23.7B
$15.2M 0.88%
575,428
-720
-0.1% -$22.4K
MMS icon
36
Maximus
MMS
$3.1B
$15.1M 0.88%
261,047
-79,101
-23% -$4.93M
ASND icon
37
Ascendis Pharma A/S
ASND
$16.8B
$14.1M 0.82%
136,445
-26,543
-16% -$2.52M
IAA
38
DELISTED
IAA, Inc. Common Stock
IAA
$14M 0.81%
440,877
-131,040
-23% -$4.65M
BBBY
39
Bed Bath & Beyond
BBBY
$442M
$13.8M 0.8%
621,818
+22,201
+4% +$557K
IOVA icon
40
Iovance Biotherapeutics
IOVA
$2.87B
$13.7M 0.8%
1,434,056
-267,135
-16% -$3.08M
CEVA icon
41
CEVA Inc
CEVA
$1.08B
$13.4M 0.78%
512,382
-51,822
-9% -$1.66M
LMAT icon
42
LeMaitre Vascular
LMAT
$1.86B
$13.3M 0.77%
262,364
-4,390
-2% -$219K
BHVN
43
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$12.4M 0.72%
82,110
-180,920
-69% -$26.8M
ARLO icon
44
Arlo Technologies
ARLO
$1.65B
$10.6M 0.61%
2,274,316
+474,105
+26% +$2.97M
SIMO icon
45
Silicon Motion
SIMO
$8.68B
$10M 0.58%
153,983
-188,707
-55% -$14.8M
UTMD icon
46
Utah Medical Products
UTMD
$225M
$10M 0.58%
117,538
-1,352
-1% -$119K
PRGS icon
47
Progress Software
PRGS
$1.76B
$9.85M 0.57%
231,514
-5,816
-2% -$269K
ALBO
48
DELISTED
Albireo Pharma Inc
ALBO
$9.76M 0.57%
504,138
+38,334
+8% +$793K
KNSA icon
49
Kiniksa Pharmaceuticals
KNSA
$5.93B
$9.63M 0.56%
749,933
-64,740
-8% -$738K
CNTY icon
50
Century Casinos
CNTY
$34M
$9.21M 0.53%
1,403,710
-99,763
-7% -$769K
1
2
3 4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Rice Hall James & Associates held 279 positions worth $1.72B, down 17% from $2.07B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Rice Hall James & Associates withdrew a net $310M in Q3 2022, closing 14 positions and reducing 169 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $7.39M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in TechTarget worth $8.44M.

  • Rice Hall James & Associates's largest Q3 2022 buy was TechTarget: 142,597 shares worth $8.44M.
  • Rice Hall James & Associates added most to Upland Software in Q3 2022, an estimated $3.67M increase.
  • Rice Hall James & Associates's biggest Q3 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $26.8M.
  • Rice Hall James & Associates fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $7.39M.
  • Rice Hall James & Associates's ten largest holdings make up 23% of its $1.72B portfolio in Q3 2022.
  • Rice Hall James & Associates opened 14 new positions and closed 14 in Q3 2022.
  • Rice Hall James & Associates's portfolio value fell 17% quarter-over-quarter to $1.72B.

Based on Rice Hall James & Associates's 13F filing for Q3 2022, filed 1 Nov 2022.